February 27, 2006

Blood substitutes may be needed on the battlefield. But does that justify testing blood substitutes in trauma

Read More
Despite Undisclosed Deaths, 10 Heart Attacks FDA Allows Blood Substitute Experiment With No Conset

February 25, 2006

For years leading child psychiatrists and the National Institute of Mental Health refused to entertain evidence of

Read More
ADHD Drugs Addictive_NIDA study

February 25, 2006

The stakes are high. “Freedom can be maintained only if citizens understand the intellectual basis of scientific

Read More
‘Debate’- Case Against Scientific Validity of Mental Screens– NAS- Sci-Tech Policy Fellows Seminar

February 23, 2006

The New York Post and the Associated Press report that the federal Office ofHuman Research Protection issued

Read More
AHRP Complaint Validated: Columbia “Changes Policy” on ‘Guinea Pig’ Kids

February 13, 2006

An OpEd piece in The Boston Glob by Dr. Jerome Kassirer, distinguished Professor at Tufts, a former

Read More
How drug lobbyists influence doctors

February 13, 2006

In the wake of the fraudulent clonning reports published in the journal, Science, a report in the

Read More
Reporters Find Science Journals Harder to Trust, but Not Easy to Verify–NY Times

February 12, 2006

The New York Times editorial today got it right: "Many experts believe that attention deficit hyperactivity disorder

Read More
NYT Editorial Stimulant Warning

February 11, 2006

“While there is a lot of focus on children … the numbers tell me that the magnitude

Read More
ADHD Drug Risks: Cardiovascular and Cerebrovascular Problems

February 9, 2006

This appears to be an effort to put out a firestorm in the wake of the latest

Read More
Safety of Newborn infants Threatened by Rx antidepressants during pregnancy

February 9, 2006

Reuters reports that sudden death, high blood pressure, heart attacks and strokes have been reported in people

Read More
Which is it—51 or 186 deaths linked to ADHD drugs?

February 8, 2006

"Sham Peer Review" exists in the way hospitals and insurancecompanies hold sway on patient care. Below a

Read More
Sham Peer Review

February 7, 2006

The entire profession seems to be in the business of marketing antidepressants, encouraging rather than discouraging women–even

Read More
Israeli Study: One in 3 infants Suffer SSRI Withdrawal

February 6, 2006

People cannot make an informed treatment decision unless they know the demonstrated risks and benefits.  Following the

Read More
Weighing the Benefits & Risks of SSRI Antidepressants for Youth

February 6, 2006

The credibility of company sponsored tests of the so-called ‘atypical’ antipsychotic drugs (neuroleptics) including Johnson & Johnson

Read More
Another Study Shows: Antipsychotic Trials Biased Towards Sponsor’s Drug